- Home
- SBSI vs AMLX Comparison
SBSI vs AMLX Comparison
Compare SBSI & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBSI
- AMLX
- Stock Information
- Founded
- SBSI 1960
- AMLX 2014
- Country
- SBSI United States
- AMLX United States
- Employees
- SBSI N/A
- AMLX N/A
- Industry
- SBSI Major Banks
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- SBSI Finance
- AMLX Health Care
- Exchange
- SBSI Nasdaq
- AMLX Nasdaq
- Market Cap
- SBSI 920.2M
- AMLX 749.9M
- IPO Year
- SBSI N/A
- AMLX 2022
- Fundamental
- Price
- SBSI $27.80
- AMLX $15.79
- Analyst Decision
- SBSI Hold
- AMLX Strong Buy
- Analyst Count
- SBSI 3
- AMLX 7
- Target Price
- SBSI $34.50
- AMLX $15.14
- AVG Volume (30 Days)
- SBSI 134.8K
- AMLX 1.9M
- Earning Date
- SBSI 10-24-2025
- AMLX 11-06-2025
- Dividend Yield
- SBSI 5.20%
- AMLX N/A
- EPS Growth
- SBSI 4.30
- AMLX N/A
- EPS
- SBSI 2.81
- AMLX N/A
- Revenue
- SBSI $254,956,000.00
- AMLX N/A
- Revenue This Year
- SBSI $11.17
- AMLX N/A
- Revenue Next Year
- SBSI $5.65
- AMLX N/A
- P/E Ratio
- SBSI $9.86
- AMLX N/A
- Revenue Growth
- SBSI 6.01
- AMLX N/A
- 52 Week Low
- SBSI $25.85
- AMLX $2.60
- 52 Week High
- SBSI $38.00
- AMLX $15.91
- Technical
- Relative Strength Index (RSI)
- SBSI 40.98
- AMLX 70.10
- Support Level
- SBSI $27.05
- AMLX $13.60
- Resistance Level
- SBSI $28.53
- AMLX $15.15
- Average True Range (ATR)
- SBSI 0.59
- AMLX 1.05
- MACD
- SBSI -0.02
- AMLX -0.04
- Stochastic Oscillator
- SBSI 36.78
- AMLX 91.90
About SBSI Southside Bancshares Inc.
Southside Bancshares Inc is a bank holding company. Through its subsidiary, the Southside Bank, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.